Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

Bing Hu, Yuwen Ting, Xiaoqing Yang, Wenping Tang, Xiaoxiong Zeng, Qingrong Huang

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Abstract

Nanochemoprevention by oral consumption was developed by the encapsulation of (−)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.

Original languageEnglish (US)
Pages (from-to)2421-2423
Number of pages3
JournalChemical Communications
Volume48
Issue number18
DOIs
StatePublished - Feb 1 2012

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Electronic, Optical and Magnetic Materials
  • Ceramics and Composites
  • Chemistry(all)
  • Surfaces, Coatings and Films
  • Metals and Alloys
  • Materials Chemistry

Fingerprint Dive into the research topics of 'Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability'. Together they form a unique fingerprint.

Cite this